155 related articles for article (PubMed ID: 2905745)
1. Relapse.
Sulliger N
J Psychosoc Nurs Ment Health Serv; 1988 Jun; 26(6):20-3. PubMed ID: 2905745
[No Abstract] [Full Text] [Related]
2. Strategies for enhancing drug therapy of schizophrenia.
Schooler NR; Levine J
Am J Psychother; 1983 Oct; 37(4):521-32. PubMed ID: 6140869
[TBL] [Abstract][Full Text] [Related]
3. [The problem of drug compliance in schizophrenic patients].
Albus M
Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
[No Abstract] [Full Text] [Related]
4. Supersensitivity psychosis.
Peet M
J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
[No Abstract] [Full Text] [Related]
5. Psychotic recurrence after antipsychotic discontinuation.
Zipursky RB
Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
[No Abstract] [Full Text] [Related]
6. Pharmacological treatment of schizophrenia.
Leucht S; Heres S; Kissling W; Davis JM
Fortschr Neurol Psychiatr; 2013 May; 81(5):e1-13. PubMed ID: 23702802
[TBL] [Abstract][Full Text] [Related]
7. The concept of supersensitivity psychosis.
Kirkpatrick B; Alphs L; Buchanan RW
J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269
[TBL] [Abstract][Full Text] [Related]
8. [Compliance in therapy of schizophrenic patients with neuroleptics--an overview].
Mayer C; Soyka M
Fortschr Neurol Psychiatr; 1992 Jun; 60(6):217-22. PubMed ID: 1353747
[TBL] [Abstract][Full Text] [Related]
9. Compliance, quality assurance and standards for relapse prevention in schizophrenia.
Kissling W
Acta Psychiatr Scand Suppl; 1994; 382():16-24. PubMed ID: 7916524
[TBL] [Abstract][Full Text] [Related]
10. The natural course of schizophrenia and effective maintenance drug treatment.
Davis JM; Andriukaitis S
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
[TBL] [Abstract][Full Text] [Related]
11. Ideal and reality of neuroleptic relapse prevention.
Kissling W
Br J Psychiatry Suppl; 1992 Oct; (18):133-9. PubMed ID: 1356363
[No Abstract] [Full Text] [Related]
12. Good medical practice in antipsychotic pharmacotherapy.
Peuskens J
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S35-41. PubMed ID: 9690969
[TBL] [Abstract][Full Text] [Related]
13. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients.
McEvoy JP; Howe AC; Hogarty GE
J Nerv Ment Dis; 1984 Jul; 172(7):412-6. PubMed ID: 6144721
[TBL] [Abstract][Full Text] [Related]
14. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
15. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
Hogarty GE
J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
[TBL] [Abstract][Full Text] [Related]
16. Factors which can make patients difficult to treat.
Kane JM
Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
[No Abstract] [Full Text] [Related]
17. Management of treatment resistant schizophrenia unresponsive to clozapine.
Barnes TR; McEvedy CJ; Nelson HE
Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
[No Abstract] [Full Text] [Related]
18. Important issues in the drug treatment of schizophrenia.
Davis JM; Schaffer CB; Killian GA; Kinard C; Chan C
Schizophr Bull; 1980; 6(1):70-87. PubMed ID: 6102795
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of schizophrenia: what the family doctor should know].
Gruber O; Falkai P
MMW Fortschr Med; 2008 May; 150 Suppl 2():16-9; quiz 20. PubMed ID: 18680837
[No Abstract] [Full Text] [Related]
20. [Combining effectiveness and tolerance].
Krankenpfl J; 2005; 43(1-3):26-7. PubMed ID: 15912821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
